About this trial
The clinical diagnosis and treatment data of 300 cases of cervical neuroendocrine tumors were collected, including age, preoperative biopsy pathology results, postoperative histopathological results, TCT results, and colposcopy biopsy pathology results. At the same time, paraffin tissue specimens (remaining specimens after pathological diagnosis) from 100 cases of cervical neuroendocrine tumors from multiple centers across the country were collected to establish a cervical neuroendocrine tumor data follow-up database. Protein concentration and omics analysis were performed on the data results, to evaluate the molecular characteristics and prognosis of cervical neuroendocrine tumor proteins, and to preliminarily explore its clinical application value.
Eligibility criteria
Qualifiers
Patients diagnosed with cervical neuroendocrine carcinoma by histopathology
Clinical data were complete
Disqualifiers
Patients who are not being treated in our hospital
Patients with lack of follow-up data, unable to obtain survival information
Patients call to refuse to participate in this project
The quality of paraffin specimens can not meet the requirements of proteome concentration determination
Trial design
Treatments tested in this trial
- Not listed